Welcome to our dedicated page for M Evo Global Acquisition II SEC filings (Ticker: MEVOU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on M Evo Global Acquisition II's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into M Evo Global Acquisition II's regulatory disclosures and financial reporting.
Aristeia Capital, L.L.C. reports beneficial ownership of 1,833,442 Class A ordinary shares of MEVO GLOBAL ACQUISITION CORP. This holding represents 6.11% of the Class A shares, based on 30,000,000 shares outstanding as of May 8, 2026 as cited in the issuer's 8-K.
The filing states Aristeia has sole voting and sole dispositive power over all 1,833,442 shares. The Schedule 13G was signed by Andrew B. David on May 14, 2026.
Aristeia Capital, L.L.C. reports beneficial ownership of 1,833,442 Class A ordinary shares of MEVO GLOBAL ACQUISITION CORP. This holding represents 6.11% of the Class A shares, based on 30,000,000 shares outstanding as of May 8, 2026 as cited in the issuer's 8-K.
The filing states Aristeia has sole voting and sole dispositive power over all 1,833,442 shares. The Schedule 13G was signed by Andrew B. David on May 14, 2026.
M Evo Global Acquisition Corp II ownership filing reports that Adage Capital Management, L.P. (with Robert Atchinson and Phillip Gross) holds 2,430,000 Class A ordinary shares, representing 8.10% of the class based on 30,000,000 shares outstanding as of February 2, 2026.
The filing states these shares are held through Adage-managed entities with shared voting and dispositive power. The signatories executed a joint filing agreement to report the position.
M Evo Global Acquisition Corp II ownership filing reports that Adage Capital Management, L.P. (with Robert Atchinson and Phillip Gross) holds 2,430,000 Class A ordinary shares, representing 8.10% of the class based on 30,000,000 shares outstanding as of February 2, 2026.
The filing states these shares are held through Adage-managed entities with shared voting and dispositive power. The signatories executed a joint filing agreement to report the position.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report shared voting and dispositive power over 1,382,662 Class A ordinary shares of M EVO GBL ACQUISITION CORP II (MEVO), representing 5.1% of the class as of 03/31/2026.
The filing is a joint Schedule 13G, signed under a joint filing agreement dated 05/07/2026, and discloses that the reported holdings are attributable to Goldman Sachs reporting units and a broker‑dealer subsidiary. The filing includes standard disclaimers about client accounts and disaggregated operating units.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report shared voting and dispositive power over 1,382,662 Class A ordinary shares of M EVO GBL ACQUISITION CORP II (MEVO), representing 5.1% of the class as of 03/31/2026.
The filing is a joint Schedule 13G, signed under a joint filing agreement dated 05/07/2026, and discloses that the reported holdings are attributable to Goldman Sachs reporting units and a broker‑dealer subsidiary. The filing includes standard disclaimers about client accounts and disaggregated operating units.
M Evo Global Acquisition Corp II, a newly formed SPAC, reported its first quarterly results after completing its IPO and establishing its trust structure.
The company raised $300,000,000 on February 2, 2026 by selling 30,000,000 units at $10.00 each, and placed that amount in a trust account. As of March 31, 2026, investments in the trust totaled $301,665,521, including $1,665,521 of interest income. Outside the trust, cash and cash equivalents were $1,035,350, providing working capital while it searches for a business combination.
For the quarter, the company recorded a net loss of $6,993,616, driven mainly by non‑cash compensation expense of $8,469,916 related to founder shares granted to officers and directors, plus $189,221 of general and administrative costs. All 30,000,000 Class A ordinary shares are classified as redeemable at about $10.06 per share, and a deferred underwriting fee of $12,000,000 will be payable only if a business combination is completed within the 24‑month window.
M Evo Global Acquisition Corp II, a newly formed SPAC, reported its first quarterly results after completing its IPO and establishing its trust structure.
The company raised $300,000,000 on February 2, 2026 by selling 30,000,000 units at $10.00 each, and placed that amount in a trust account. As of March 31, 2026, investments in the trust totaled $301,665,521, including $1,665,521 of interest income. Outside the trust, cash and cash equivalents were $1,035,350, providing working capital while it searches for a business combination.
For the quarter, the company recorded a net loss of $6,993,616, driven mainly by non‑cash compensation expense of $8,469,916 related to founder shares granted to officers and directors, plus $189,221 of general and administrative costs. All 30,000,000 Class A ordinary shares are classified as redeemable at about $10.06 per share, and a deferred underwriting fee of $12,000,000 will be payable only if a business combination is completed within the 24‑month window.
M Evo Global Acquisition Corp II is allowing investors to trade the components of its units separately. Beginning on or about February 19, 2026, holders of units can elect to trade the Class A ordinary shares and redeemable warrants independently on Nasdaq.
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share. Units will continue to trade under the symbol MEVOU, while separated Class A shares and warrants will trade under MEVO and MEVOW, respectively.
Investors who want to separate their units must have their brokers contact Continental Stock Transfer & Trust Company, the transfer agent. The company remains a special purpose acquisition company focused on potential business combinations in the critical minerals sector.
M Evo Global Acquisition Corp II completed its initial public offering of 30,000,000 units at $10.00 per unit, raising gross proceeds of $300,000,000. Each unit includes one Class A ordinary share and one-half of a redeemable warrant exercisable at $11.50 per share.
The company also sold 8,000,000 private placement warrants for $8,000,000 and deposited $300,000,000 into a trust account for the benefit of public shareholders. An audited balance sheet shows total assets of $301,392,166, including $1,217,506 of cash outside the trust and a shareholders’ deficit of $10,767,164.
M Evo Global Acquisition Corp II launched an initial public offering of 27,000,000 units at $10.00 per unit for aggregate gross proceeds of $270,000,000. Each unit comprises one Class A ordinary share and one-half redeemable warrant; whole warrants exercisable at $11.50.
The offering places $270,000,000 (or $300,000,000 with full over‑allotment) into a U.S.-based trust account, gives public shareholders redemption rights in connection with an initial business combination, and sets a 24 months completion window to effect a business combination focused on the critical minerals sector. Founder and private placement interests (including 10,000,000 founder shares and 7,400,000 private placement warrants) and anti-dilution provisions may materially dilute public shareholders upon a business combination.